Evidence map›Paper›PMID 42741211›Full record

ArticleFrontiers in oncology2026

Interpretable machine-learning risk stratification at the time of diagnosis for 3-year mortality in

Xin Wang, Guanglei Yao, Heqian Liu, Wei Ding

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xin Wang *Department of Urology, The Second People's Hospital of Wuhu, Wuhu, Anhui, China.
Guanglei Yao *Department of Urology, The Second People's Hospital of Wuhu, Wuhu, Anhui, China.
Heqian Liu *Department of Urology, The Second People's Hospital of Wuhu, Wuhu, Anhui, China.
Wei DingDepartment of Urology, The Second People's Hospital of Wuhu, Wuhu, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Men with

Indexed as

cancer-specific mortalityCatBoostexplainable artificial intelligencemachine learningmetastatic prostate cancerprognostic modelrisk stratificationSEER

Identifiers

PMID42741211
PMCPMC13572273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.